Monte Rosa Therapeutics
GLUE
GLUE
68 hedge funds and large institutions have $281M invested in Monte Rosa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
4% less funds holding
Funds holding: 71 → 68 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
68
Holding in Top 10
2
Calls
$685K
Puts
$96K
Top Buyers
| 1 | +$1.1M | |
| 2 | +$851K | |
| 3 | +$583K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$341K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$337K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$763K | |
| 3 | -$756K | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$512K |
| 5 |
BlackRock
New York
|
-$458K |